Interviews/Contributions
Investor Insights: Mike Carusi Lightstone Ventures – Investment size, typical investment
Investor Insights: Mike Carusi Lightstone Ventures – Firm and focus areas
Investor Insights – Darshana Zaveri -What do you expect to see with funding as we close out 2024
Investor Insights: Darshana Zaveri – What Stage Does Catalyst Typically Invest?
Investor Insights – Darshana Zaveri: Catalyst Health Ventures’ Focus Area
Investor Insights – Darshana Zaveri: How CEOs should prepare for a meeting with CHV
Investor Insights: Louis Cannon – BioStar Capital and their Focus, Stage, and Typical Investment (part 3)
Investor Insights: Alan Davis – BioStar Capital and their Newly Raised Fund (part 2)
Investor Insights: Louis Cannon, MD of BioStar Capital – why were different (part 1)
Recent
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
Aptyx Amplifies Expertise in Complex Interventional Products With Acquisition of Medical Murray’s North Carolina Facility
![Life Molecular Imaging Secures FDA Fast Track Designation for [18F]Florbetaben in Diagnosing Cardiac AL and ATTR Amyloidosis](https://cardiacvascularnews.com/wp-content/uploads/2025/01/Life-molecular-imaging-e1737489511884-90x60.png)
Life Molecular Imaging Secures FDA Fast Track Designation for [18F]Florbetaben in Diagnosing Cardiac AL and ATTR Amyloidosis
Popular
- No commented posts yet